Antiseptic Barrier Caps Effects on Central Line Associated Bloodstream Infections (CLABSIs)
Advisor(s)
Jamie Hunsicker
Confirmation
1
Document Type
Poster
Location
ONU McIntosh Center; Activities Room
Start Date
11-4-2025 11:00 AM
End Date
11-4-2025 11:50 AM
Abstract
Problem: Many of the most critically ill patients have central venous catheters (CVCs) that are used daily for medication administration and blood sample collection. CVCs increase the risk of getting a central line associated bloodstream infection (CLABSI). CLABSIs increase complications of already critically ill patients and increase risk of morbidity and mortality. The use of antiseptic barrier caps may be used to decrease the risk of a CLABSI.
Purpose: The purpose of this project is to identify if the use of antiseptic barrier caps are effective in lowering the rates of CLABSIs in hospitalized patients.
Method: The number of CLABSIs on this specific unit will be compared six months before implementation and six months after implementation on an intensive care unit (ICU). Participants will include any patient who has a CVC. Nurses will be educated on the use of antiseptic barrier caps and nurse managers will do random assessments to ensure compliance.
Conclusion: Antiseptic barrier caps have been shown to decrease the number of CLABSIs in the ICU. Prevention of CLABSIs improves patient outcomes and decreases costs to the organizations that are related to hospital acquired infections. Nurses have found antiseptic barrier caps to be an effective method of prevention that also is more time efficient. Health care systems should use antiseptic barrier caps as a method to prevent CLABSIs.
Recommended Citation
Altiere, Olivia N., "Antiseptic Barrier Caps Effects on Central Line Associated Bloodstream Infections (CLABSIs)" (2025). ONU Student Research Colloquium. 51.
https://digitalcommons.onu.edu/student_research_colloquium/2025/Posters/51
Restricted
Available to ONU community via local IP address and ONU login.
Antiseptic Barrier Caps Effects on Central Line Associated Bloodstream Infections (CLABSIs)
ONU McIntosh Center; Activities Room
Problem: Many of the most critically ill patients have central venous catheters (CVCs) that are used daily for medication administration and blood sample collection. CVCs increase the risk of getting a central line associated bloodstream infection (CLABSI). CLABSIs increase complications of already critically ill patients and increase risk of morbidity and mortality. The use of antiseptic barrier caps may be used to decrease the risk of a CLABSI.
Purpose: The purpose of this project is to identify if the use of antiseptic barrier caps are effective in lowering the rates of CLABSIs in hospitalized patients.
Method: The number of CLABSIs on this specific unit will be compared six months before implementation and six months after implementation on an intensive care unit (ICU). Participants will include any patient who has a CVC. Nurses will be educated on the use of antiseptic barrier caps and nurse managers will do random assessments to ensure compliance.
Conclusion: Antiseptic barrier caps have been shown to decrease the number of CLABSIs in the ICU. Prevention of CLABSIs improves patient outcomes and decreases costs to the organizations that are related to hospital acquired infections. Nurses have found antiseptic barrier caps to be an effective method of prevention that also is more time efficient. Health care systems should use antiseptic barrier caps as a method to prevent CLABSIs.